关节炎导致的活动限制的患病率 - 美国,2023,
Ellen W Stowe1, Daniel K White2, Michael A Boring3
1Centers for Disease Control and Prevention, Atlanta, Georgia.
Arthritis care & research
|December 16, 2025
概括
美国近一半患有关节炎的成年人经历了活动限制. 尽管略有下降,但健康人2030年减少关节炎归因活动限制 (AAAL) 的目标在2019年至2023年之间没有实现.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 老年学是一门学科.
背景情况:
- 关节炎影响数百万美国成年人,往往导致活动限制.
- 关节炎归因于活动限制 (AAAL) 是公共卫生倡议的一个关键指标.
- "健康人2030"框架旨在减少AAAL的流行率.
研究的目的:
- 为了估计2023年美国成年患有关节炎的人群中AAAL的流行率.
- 根据社会人口统计和健康特征分析AAAL的流行情况.
- 评估朝着健康人2030年AAAL减少目标的进展.
主要方法:
- 利用了来自2019年和2023年国家健康访谈调查的横截面数据.
- 美国成年人诊断患有关节炎的估计未调整和年龄标准化的AAAL患病率.
- 使用t测试来评估AAAL流行率在各种特征和调查年之间的差异.
主要成果:
- 在2023年,AAAL年龄调整后的患病率为47.8% (24.8百万成年人).
- 在各个社会人口统计和健康群体中观察到AAAL患病率的显著差异.
- 在AAAL患病率的非统计学显著下降发生,从2019年的49.2%降至2023年的47.8%.
结论:
- 大约一半的美国成年人患有关节炎报告活动限制.
- 健康人2030年AAAL的46.8%的目标流行率没有实现.
- 实施基于证据的干预措施对于实现"健康人2030"AAAL减少目标至关重要.
相关概念视频
Genome-wide Association Studies-GWAS
15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.2K
Prevalence and Incidence
1.5K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.5K
The JAK-STAT Signaling Pathway
11.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.8K
Atherosclerosis III: Management
293
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
293
Rheumatic Heart Disease III: Medical Management
264
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
264
Peripheral Artery Disease III: Interprofessional Care
221
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
221


